Advertisement

Topics

Integral Molecular reaches milestone in I-O target discovery collaboration with Daiichi Sankyo

20:00 EDT 13 Jun 2019 | AAAS

(Integral Molecular) Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, announced that it has successfully reached the first milestone in its collaboration with Daiichi Sankyo Co., Ltd. to discover new immuno-oncology (I-O) therapeutic targets.

Original Article: Integral Molecular reaches milestone in I-O target discovery collaboration with Daiichi Sankyo

NEXT ARTICLE

More From BioPortfolio on "Integral Molecular reaches milestone in I-O target discovery collaboration with Daiichi Sankyo"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...